dc.contributor.author |
VISHWESHWARA, SHARATH S. |
en_US |
dc.contributor.author |
ANAND, SAURABH |
en_US |
dc.contributor.author |
BHOGE, PREETI RAVINDRA |
en_US |
dc.contributor.author |
MAHIDA, VIRENDRASINH |
en_US |
dc.contributor.author |
CHANDRA, ANKITA |
en_US |
dc.contributor.author |
Vinod Saladi, Srinivas |
en_US |
dc.contributor.author |
KIKKERI, RAGHAVENDRA |
en_US |
dc.date.accessioned |
2025-06-13T06:00:05Z |
|
dc.date.available |
2025-06-13T06:00:05Z |
|
dc.date.issued |
2025-06 |
en_US |
dc.identifier.citation |
Journal of Medicinal Chemistry, 68(11), 11979–11989. |
en_US |
dc.identifier.issn |
0022-2623 |
en_US |
dc.identifier.issn |
1520-4804 |
en_US |
dc.identifier.uri |
https://doi.org/10.1021/acs.jmedchem.5c00845 |
en_US |
dc.identifier.uri |
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/10178 |
|
dc.description.abstract |
Targeted lysosomal degradation of proteins (LDP) represents a promising strategy for clearing unwanted toxic extracellular and secreted proteins. Yet, significant challenges persist, including identifying potential ligands for these proteins and lysosome-driving probes capable of facilitating their internalization and degradation through receptor-mediated endocytosis. Herein, we show that synthetic neoproteoglycan probes stably anchor to the cell membrane, facilitate the internalization of amyloid-β (Aβ) peptide into the lysosomal compartment, and mediate the programmed death of Aβ. We have identified sulfated oligo l-idose tetrasaccharide (ID49) and heparan sulfate hexasaccharides (HH26S) as potential ligands for Aβ1–42 peptide. When these molecules are expressed on the peptide-based fluorescent neoproteoglycan backbone, PG@HH26S persists on the cell membrane and facilitates Aβ1–42 endocytosis to the lysosomal compartment and subsequent targeted degradation of Aβ1–42. Overall, neoproteoglycans open a new avenue to generate LDP for degrading HS-binding proteins, including growth factors, morphogens, and toxic secreted proteins. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
American Chemical Society |
en_US |
dc.subject |
Degradation |
en_US |
dc.subject |
Fluorescence |
en_US |
dc.subject |
Ligands |
en_US |
dc.subject |
Peptides and proteins |
en_US |
dc.subject |
Toxicity |
en_US |
dc.subject |
2025-JUN-WEEK2 |
en_US |
dc.subject |
TOC-JUN-2025 |
en_US |
dc.subject |
2025 |
en_US |
dc.title |
Heparan Sulfate-Based Neoproteoglycan for Targeted Lysosomal Degradation of Amyloid-β |
en_US |
dc.type |
Article |
en_US |
dc.contributor.department |
Dept. of Chemistry |
en_US |
dc.identifier.sourcetitle |
Journal of Medicinal Chemistry |
en_US |
dc.publication.originofpublisher |
Foreign |
en_US |